More wonk stuff from Ash, page-4

First 4 Last

Share
Profile

Follow
billy duckworth

1,616 Posts.

1

16/03/18

07:19

Post #: 31794577
Share

Originally posted by Ashentegra ↑

Billy,

That is all very flattering. I have used HC to try to work through my thoughts and understanding. Sorry if I inflict upon other investors who simply want binary answers to buy/sell.

I believe the issues confronting IFN are hard but do-able.

Refinance without the cash sweep conditions should happen by 31 March, but still at a relatively high interest rate. Investors will expect unconditional/cheap finance but this doesn't look possible. It is easy to jeer from the cheap seats.

Batteries are a priority, with immediate savings on frequency stabilisation ~$6m pa and despatch optionality exchanging off-peak production for peak supply. But large-scale batteries are hard to source cos everyone wants them.

Bodangora begins production June-August, with immediate cash and optionality benefits. This is a really big thing, adding 25% to output.

Cherry Tree is ready to commence construction. It would be nice to up-scale with bigger turbines but the Vic govt probably said no. Other projects seem much more distant and I an not sure why. There are big SA projects available yet no progress.

We marvel at the falling cost of wind turbines. However, this also discounts built/operating kit, making these assets less valuable. Hmmm.

Wind is an ideal compliment to solar. Solar is dispersed; wind is concentrated in few hands. I also like the EBIDTA margins. This business deserves a solid P/E.

There are many moving parts to the IFN equation and it would be easy for the BoD to make a serious mistake.

The refinance should unjam the balance sheet. The BoD will then be able to commit to significant expansion - within weeks, not months. I think the SP will then move up vigorously. That is how I am betting.

Ash

Expand

Thanks, Ash. Always value your feedback.

IFN Price at posting: 58.5¢ Sentiment: Buy Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

KLV

Klevo Rewards advances stablecoin strategy with credit licence acquisition

DBO

Diablo expands critical minerals footprint at Star Range

OMA

Omega Oil & Gas kicks off play-defining drilling campaign at Canyon-3

PL9

Prairie Lithium advances towards first production as commercial DLE unit arrives

HotCopper Highlights, Week 31: Pilbara Minerals, BrainChip and 4DMedical spark fresh investor interest

AFP

AFT Pharmaceutical's multi-billion R&D opportunity

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 43.8¢		Change 0.023(5.42%)		Mkt cap ! $91.25M

Open	High	Low	Volume
40.5¢	43.8¢	40.5¢	14.52K

Buyers (Bids)

Vol.	Price($)
4	43.5¢

Sellers (Offers)

Price($)	Vol.
45.0¢	70000

Last trade - 16.00pm 31/07/2026 (20 minute delay)

IFN (ASX) Chart

More wonk stuff from Ash, page-4

Top Stories

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Diablo expands critical minerals footprint at Star Range

Omega Oil & Gas kicks off play-defining drilling campaign at Canyon-3

Prairie Lithium advances towards first production as commercial DLE unit arrives

HotCopper Highlights, Week 31: Pilbara Minerals, BrainChip and 4DMedical spark fresh investor interest

AFT Pharmaceutical's multi-billion R&D opportunity

Buyers (Bids)

Sellers (Offers)